Skip to main content
University of Michigan Innovation Partnerships
University of Michigan Innovation Partnerships

Portfolio

ViewPoint Therapeutics

Biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts.
(2016)

Argessin

GPCR inhibitors for Parkinson's disease and chronic pain
(2015)

Confo Therapeutics

Drug discovery platform using novel antibody fragments
(2015)

FlexDex Surgical

Laparoscopy tool that provides surgeons with greater dexterity and natural motion when sewing sutures
(2015)

Ivogen

Novel therapeutic approach to treat pathogenic bacteria.
(2015)

Kura Oncology

Precision medicine for cancer
(2015)

Medsyn Biopharma LLC

Therapeutics for cancer
(2015)

Opsidio, LLC

Therapeutic monoclonal antibody for pulmonary fibrosis/asthma/fibrotic lung disease
(2015)

PFS Genomics

Personalized treatment methodologies for breast cancer
(2015)

Rapid Oxygen Company

Portable emergency oxygen delivery system
(2015)

ONL Therapeutics

FAS apoptosis inhibitors to protect photoreceptors and preserve patient vision from retinal diseases.  ONL is focused on preventing the death of key retinal cells, including photoreceptors—the root cause of vision loss and the leading cause of blindness.
(2014)

PhasiQ

Solution microarrays for sensitive quantitation of any combination of protein biomarkers without false signals
(2014)

Arborlight, LLC

Dynamic daylight emulation system with environmental feedback controls
(2013)

Millendo

Development of novel therapy for the treatment of adrenal cancer (Formerly Atterocor)
(2013)

OncoFusion Therapeutics, Inc.

Personalized therapeutics for patients with genetically defined cancers
(2013)

AlertWatch

Produces patient monitoring and clinical decision support systems OR and ICU.
(2012)

ChemXlerate

Tools to identify crystalline forms of active pharmaceutical ingredients
(2012)

Diapin Therapeutics

Peptide-based therapies for diabetes
(2012)
1 3 4 5 6 7 8 9 11